Tele: 561.316.3330
Breaking Medical Device News

Tuesday, October 19, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeRPS Diagnostics

RPS Diagnostics

FebriDx® Receives Updated CE Mark to Allow Incorporation of All-in-One Test Format

FebriDx provides clinicians with a 10-minute assessment of the body’s immune response to an acute respiratory infection (ARI) directly from a fingerstick blood sample.

New Clinical Trial Demonstrates that FebriDx Can Accurately Identify Clinically Significant Bacterial Infections and May Support Outpatient Antibiotic Stewardship

5/21/18: “The overuse of antibiotics is a significant and growing problem,” said Robert Sambursky, MD, RPS Diagnostics’ President and Chief Executive Officer. “FebriDx provides clinicians a tool for rapidly measuring an immune response. This information facilitates clinical decision making and reduces unnecessary antibiotic prescribing.”

By using this website you agree to accept Medical Device News Magazine Privacy Policy